clinical implications of ‘low’ her2 expression: 2023 best of breast conference
Published 1 year ago • 119 plays • Length 4:12Download video MP4
Download video MP3
Similar videos
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference
-
6:29
hot topics in advanced breast cancer: 2023 best of breast conference
-
1:00:01
her2 mbc | 2023 best of breast conference
-
20:55
lightning updates | 2023 best of breast conference
-
46:31
adjuvant therapy | 2023 best of breast conference
-
2:43
sequencing treatment options in her2 positive breast cancer: 2023 best of breast conference
-
24:07
lightning updates from major meetings | 2023 best of breast conference
-
1:08:58
tnbc current and emerging therapeutic strategies | 2023 best of breast conference
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
35:58
her2 ihc interpretation guide (examples and challenging scenarios)
-
1:03:23
targeted therapies precision medicine approaches | 2023 best of breast conference
-
1:01:50
her2 breast cancer case panel discussion | 2022 best of breast conference
-
1:35
issues in triple negative breast cancer: 2023 best of breast conference
-
1:25:22
a new view of the spectrum of her2 expression and significance of her2 low in breast cancer
-
1:20:02
her2-low expression in breast cancer: opportunities for expanding treatment benefit to more patients
-
36:33
breast cancer case-based panel discussion | 2022 midwest women's cancer conference
-
58:39
high-risk patient breast cancer case panel discussion | 2022 best of breast conference
-
53:17
patients with high risk features | 2023 best of breast conference
-
57:59
breast cancer patient perspectives panel discussion | 2022 best of breast conference
-
22:57
2022 west oncology conference | breast cancers | metastatic